全文获取类型
收费全文 | 5790篇 |
免费 | 431篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 49篇 |
儿科学 | 120篇 |
妇产科学 | 101篇 |
基础医学 | 675篇 |
口腔科学 | 67篇 |
临床医学 | 775篇 |
内科学 | 1184篇 |
皮肤病学 | 93篇 |
神经病学 | 475篇 |
特种医学 | 163篇 |
外科学 | 981篇 |
综合类 | 47篇 |
一般理论 | 3篇 |
预防医学 | 518篇 |
眼科学 | 86篇 |
药学 | 434篇 |
中国医学 | 7篇 |
肿瘤学 | 454篇 |
出版年
2023年 | 59篇 |
2022年 | 102篇 |
2021年 | 317篇 |
2020年 | 180篇 |
2019年 | 243篇 |
2018年 | 270篇 |
2017年 | 190篇 |
2016年 | 166篇 |
2015年 | 250篇 |
2014年 | 256篇 |
2013年 | 364篇 |
2012年 | 461篇 |
2011年 | 490篇 |
2010年 | 237篇 |
2009年 | 164篇 |
2008年 | 291篇 |
2007年 | 279篇 |
2006年 | 298篇 |
2005年 | 216篇 |
2004年 | 207篇 |
2003年 | 185篇 |
2002年 | 157篇 |
2001年 | 80篇 |
2000年 | 66篇 |
1999年 | 63篇 |
1998年 | 33篇 |
1997年 | 30篇 |
1996年 | 31篇 |
1995年 | 31篇 |
1994年 | 12篇 |
1993年 | 20篇 |
1992年 | 44篇 |
1991年 | 41篇 |
1990年 | 41篇 |
1989年 | 33篇 |
1988年 | 28篇 |
1987年 | 27篇 |
1986年 | 24篇 |
1985年 | 32篇 |
1984年 | 27篇 |
1983年 | 13篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1974年 | 11篇 |
1973年 | 13篇 |
1971年 | 13篇 |
1970年 | 12篇 |
1968年 | 14篇 |
1967年 | 8篇 |
1966年 | 13篇 |
排序方式: 共有6232条查询结果,搜索用时 0 毫秒
91.
92.
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. 总被引:5,自引:2,他引:5
No reports of the incidence rates for primary systemic amyloidosis (AL) have come to our attention. Records of all residents of Olmstead County, Minnesota, with a diagnosis of amyloidosis were obtained from the Mayo Clinic and its affiliated hospitals, as well as other medical groups that might have seen local patients for the period January 1, 1950 to December 31, 1989. Twenty-one patients fulfilled the criteria for the diagnosis of AL. The median age was 73.5 years, and 62% were men. In all but one patient the diagnosis was made ante mortem. The clinical data of the 21 patients were similar to those referral patients with AL seen at Mayo Clinic. Immunohistochemical stains were positive for monoclonal light chains in the amyloid deposits in 15 of the 21 cases. In six cases, tissue was not available for immunohistochemical studies. Three of the six patients without immunohistochemical stains had a free monoclonal lambda light chain in the urine, and the other three had a monoclonal serum protein. Immunoelectrophoresis/immunofixation detected a monoclonal (M)-protein in the serum of 16 of 17 patients tested. A monoclonal light chain was found in the urine of 10 of 15 patients. The overall sex- and age-adjusted rate per million person-years was 6.1 from 1950 to 1969 and 10.5 from 1970 to 1989. The similarity of these rates suggests no significant increase over time. 相似文献
93.
Global vascular expression of murine CD34, a sialomucin-like endothelial ligand for L-selectin 总被引:19,自引:2,他引:19
Extravasation of leukocytes into organized lymphoid tissues and into sites of inflammation is critical to immune surveillance. Leukocyte migration to peripheral lymph nodes (PLN), mesenteric lymph nodes (MLN) and Peyer's patches (PP) depends on L-selectin, which recognizes carbohydrate-bearing, sialomucin-like endothelial cell surface glycoproteins. Two of these ligands have been identified at the molecular level. One is the potentially soluble mucin, GlyCAM 1, which is almost exclusively produced by high endothelial venules (HEV) of PLN and MLN. The second HEV ligand for L-selectin is the membrane-bound sialomucin CD34. Historically, this molecule has been successfully used to purify human pluripotent bone marrow stem cells, and limited data suggest that human CD34 is present on the vascular endothelium of several organs. Here we describe a comprehensive analysis of the vascular expression of CD34 in murine tissues using a highly specific antimurine CD34 polyclonal antibody. CD34 was detected on vessels in all organs examined and was expressed during pancreatic and skin inflammatory episodes. A subset of HEV-like vessels in the inflamed pancreas of nonobese diabetic (NOD) mice are positive for both CD34 and GlyCAM 1, and bind to an L-selectin/immunoglobulin G (IgG) chimeric probe. Finally, we found that CD34 is present on vessels of deafferentiated PLN, despite the fact that these vessels are no longer able to interact with L-selectin or support lymphocyte binding in vitro or trafficking in vivo. Our data suggest that the regulation of posttranslational carbohydrate modifications of CD34 is critical in determining its capability to act as an L-selectin ligand. Based on its ubiquitous expression, we propose that an appropriately glycosylated form of vascular CD34 may act as a ligand for L-selectin-mediated leukocyte trafficking to both lymphoid and nonlymphoid sites. 相似文献
94.
The personal and social context of planning for end-of-life care 总被引:1,自引:0,他引:1
OBJECTIVES: To examine the potential facilitators of or deterrents to end-of-life planning for community-dwelling older adults, including personal (health-related and sociodemographic) and social (physician and family) influences. DESIGN: In-person interviews with older adults, telephone interviews with physicians and family members. SETTING: Cleveland, Ohio. PARTICIPANTS: Two hundred thirty-one adults aged 65 to 99 who were aging in place, 99 of their primary care physicians, and 127 of their family members. MEASUREMENTS: Questions assessing older adults' discussions with others about end-of-life plans, implementation of advance directives, and physical (Older American Resources and Services) illness index and mental (Short Portable Mental Status Questionnaire) health status. RESULTS: Just fewer than half of older adults had executed an advance directive and discussed their wishes with others. Only personal characteristics of elderly individuals were related to end-of-life plans, with whites, unmarried individuals, and younger adults more likely to have made preparations. Older adults' health status, as evaluated by the patient, physician, and caregiver, did not relate to the tendency to have made advance care plans. Older adults' family members were much more likely to report knowledge of advance care plans than were physicians. CONCLUSION: These findings suggest that many physicians are not talking with their patients about their end-of-life wishes. Furthermore, the propensity to have such discussions may relate more to the personal preferences and level of comfort of patients, physicians, and family members than on the health status of the older adult. 相似文献
95.
Reduced bleeding events with subcutaneous administration of recombinant human factor IX in immune-tolerant hemophilia B dogs
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Russell KE Olsen EH Raymer RA Merricks EP Bellinger DA Read MS Rup BJ Keith JC McCarthy KP Schaub RG Nichols TC 《Blood》2003,102(13):4393-4398
Intravenous administration of recombinant human factor IX (rhFIX) acutely corrects the coagulopathy in hemophilia B dogs. To date, 20 of 20 dogs developed inhibitory antibodies to the xenoprotein, making it impossible to determine if new human FIX products, formulations, or methods of chronic administration can reduce bleeding frequency. Our goal was to determine whether hemophilia B dogs rendered tolerant to rhFIX would have reduced bleeding episodes while on sustained prophylactic rhFIX administered subcutaneously. Reproducible methods were developed for inducing tolerance to rhFIX in this strain of hemophilia B dogs, resulting in a significant reduction in the development of inhibitors relative to historical controls (5 of 12 versus 20 or 20, P <.001). The 7 of 12 tolerized hemophilia B dogs exhibited shortened whole blood clotting times (WBCTs), sustained detectable FIX antigen, undetectable Bethesda inhibitors, transient or no detectable antihuman FIX antibody titers by enzyme-linked immunosorbent assay (ELISA), and normal clearance of infused rhFIX. Tolerized hemophilia B dogs had 69% reduction in bleeding frequency in year 1 compared with nontolerized hemophilia B dogs (P =.0007). If proven safe in human clinical trials, subcutaneous rhFIX may provide an alternate approach to prophylactic therapy in selected patients with hemophilia B. 相似文献
96.
Brain aromatase: dyed-in-the-wool homosexuality 总被引:1,自引:0,他引:1
97.
Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis 总被引:2,自引:0,他引:2
OBJECTIVE: To examine the relationship between international normalized ratio (INR) and outcomes (major bleeding events and strokes) in patients with atrial fibrillation (AF) receiving anticoagulation with warfarin. METHODS: A systematic review and metaanalysis of studies published in the English language between January 1, 1985, and October 30, 2002, was performed. MEDLINE (PubMed), Current Contents, and relevant reference lists were searched. Studies enrolling patients with nonvalvular AF receiving warfarin anticoagulation were eligible for inclusion if they reported stroke and/or major bleeding events in relation to INR, or time spent in therapeutic range. The risk of bleeds in overanticoagulated patients (INR > 3) and the risk of strokes in underanticoagulated patients (INR < 2) were assessed. RESULTS: Twenty-one studies (6,248 patients) met all inclusion criteria. Of the 21 studies, a target conventional INR of 2 to 3 was used in 9 studies. An INR < 2, compared with an INR > or = 2, was associated with an odds ratio (OR) for ischemic events of 5.07 (95% confidence interval [CI], 2.92 to 8.80). An INR > 3, compared with an INR < or = 3, was associated with an OR for bleeding events of 3.21 (95% CI, 1.24 to 8.28). On average, in the four studies with a target INR range of 2 to 3, patients with AF receiving warfarin spent 61% of time within, 13% of time above, and 26% below the therapeutic range. CONCLUSION: Available evidence indicates that in patients with nonvalvular AF, the risk of ischemic stroke with insufficient warfarin anticoagulation (INR < 2), and the risk of bleeding events with overanticoagulation (INR > 3) are significantly higher relative to patients with AF maintained within the recommended INR of 2 to 3. However, the published data are sparse, heterogeneous, and primarily reported from clinical trials. More studies evaluating clinical outcomes in relation to INR are needed, especially in a real-world setting. 相似文献
98.
Arterial pulse wave velocities, pulse wave contours, and systolic time intervals were recorded in thirty-nine diabetic children and were compared with recordings taken in twenty-seven normal children. Systolic time intervals were similar in the two groups of subjects. However, brachial and aortic pulse wave velocities were significantly greater in the diabetic than in the normal children (p < 0.025 and < 0.005, respectively). Also, in the diabetic children the time interval from the incisura to the midpoint of the dicrotic wave (I-D) was significantly shortened in both the brachial (p < 0.005) and carotid (p < 0.05) pulse waves as compared to the normal children. These changes in pulse wave velocity and contour are associated with increased wall stiffness that occurs with aging and suggest that the large arteries of diabetic children may exhibit acceleration of the aging process. The severity of these changes bore no direct correlation with the degree of carbohydrate intolerance as judged by insulin requirement. 相似文献
99.
100.
The aim of this study was to determine the prevalence of low fat-free mass index (FFMI) and high and very high body fat mass index (BFMI) after lung transplantation (LTR). A total of 37 LTR patients were assessed prior to and at 1 month, 1 year and 2 years for FFM and compared to 37 matched volunteers (VOL). FFM was calculated by the Geneva equation and normalized for height (kg/m(2)). Subjects were classified as FFMI "low", 8.2 kg/m(2) in men and >11.8 kg/m(2) in women. In 23 M/14 F, body mass index (BMI) was 22.3+/-4.4 and 20.1+/-4.9 kg/m(2), respectively. The prevalence of low FFMI was 80% at 1 month and 33% at 2 years after LTR. Prevalence of very high BFMI increased and was higher in patients than VOL after LTR. The prevalence of low FFMI was high prior to and remained important 2 years after LTR, whereas BFMI was lower prior to and higher 2 years after LTR. 相似文献